Robert Hadfield is Chief Legal Officer and Sec. of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 176,819 shares of TCRT, which is worth approximately $396,074. The most recent transaction as insider was on Mar 04, 2021, when has been sold 43,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 177K
0% 3M change
0% 12M change
Total Value Held $396,074

Robert Hadfield Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 04 2021
BUY
Grant, award, or other acquisition
-
43,500 Added 19.74%
176,819 Common Stock
Jan 08 2021
SELL
Open market or private sale
$82,680 $3.12 p/Share
26,500 Reduced 16.58%
133,319 Common Stock
RH

Robert Hadfield

Chief Legal Officer and Sec.
Boston, MA

Track Institutional and Insider Activities on TCRT

Follow Alaunos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRT shares.

Notify only if

Insider Trading

Get notified when an Alaunos Therapeutics, Inc. insider buys or sells TCRT shares.

Notify only if

News

Receive news related to Alaunos Therapeutics, Inc.

Track Activities on TCRT